CDAM UK Ltd grew its position in Endava plc (NYSE:DAVA - Free Report) by 7.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,348,674 shares of the company's stock after acquiring an additional 169,147 shares during the quarter. Endava comprises 10.9% of CDAM UK Ltd's holdings, making the stock its 5th largest position. CDAM UK Ltd owned 3.98% of Endava worth $72,574,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of DAVA. Blue Trust Inc. grew its holdings in shares of Endava by 28.5% during the fourth quarter. Blue Trust Inc. now owns 1,494 shares of the company's stock worth $46,000 after purchasing an additional 331 shares during the last quarter. Precision Wealth Strategies LLC boosted its position in Endava by 4.5% during the fourth quarter. Precision Wealth Strategies LLC now owns 8,954 shares of the company's stock worth $277,000 after purchasing an additional 383 shares in the last quarter. Assetmark Inc. increased its holdings in Endava by 93.1% during the 4th quarter. Assetmark Inc. now owns 985 shares of the company's stock valued at $30,000 after acquiring an additional 475 shares in the last quarter. GAMMA Investing LLC lifted its stake in Endava by 86.4% in the 4th quarter. GAMMA Investing LLC now owns 1,607 shares of the company's stock valued at $50,000 after buying an additional 745 shares in the last quarter. Finally, Jones Financial Companies Lllp raised its stake in Endava by 20.2% in the 4th quarter. Jones Financial Companies Lllp now owns 8,284 shares of the company's stock valued at $256,000 after purchasing an additional 1,392 shares during the last quarter. Hedge funds and other institutional investors own 62.23% of the company's stock.
Analyst Upgrades and Downgrades
DAVA has been the topic of a number of recent analyst reports. Morgan Stanley increased their price target on shares of Endava from $33.00 to $35.00 and gave the stock an "equal weight" rating in a research note on Friday, January 31st. Needham & Company LLC cut their target price on shares of Endava from $43.00 to $38.00 and set a "buy" rating on the stock in a research note on Friday, February 21st. Finally, Susquehanna dropped their price objective on shares of Endava from $55.00 to $50.00 and set a "positive" rating on the stock in a research note on Friday, February 21st. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $39.10.
Read Our Latest Stock Analysis on DAVA
Endava Price Performance
Shares of NYSE DAVA traded down $1.90 during mid-day trading on Thursday, hitting $17.78. 237,644 shares of the stock were exchanged, compared to its average volume of 495,020. The stock's fifty day simple moving average is $24.59 and its two-hundred day simple moving average is $27.08. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.90 and a current ratio of 1.90. Endava plc has a twelve month low of $16.70 and a twelve month high of $34.94. The company has a market cap of $1.05 billion, a P/E ratio of 161.09, a PEG ratio of 2.26 and a beta of 1.33.
Endava (NYSE:DAVA - Get Free Report) last issued its earnings results on Thursday, February 20th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.18). Endava had a net margin of 0.74% and a return on equity of 0.89%. The business had revenue of $250.63 million during the quarter, compared to the consensus estimate of $197.33 million. As a group, analysts forecast that Endava plc will post 0.57 EPS for the current fiscal year.
Endava Profile
(
Free Report)
Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.
Read More

Before you consider Endava, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.
While Endava currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.